Milleri group streptococcus—a stepchild in the viridans family

  • Y. Siegman-Igra
  • Y. Azmon
  • D. Schwartz


The purpose of this investigation was to provide a comprehensive review of the pathogenic role and spectrum of disease of milleri group streptococci, with special attention to bloodstream invasion and to possible differential roles among the three species. All consecutive isolates of milleri group streptococci from any anatomic source, during a 37-month period, in a tertiary care teaching hospital in Tel-Aviv, Israel, were thoroughly investigated. Identification to the species level was performed by an automated system.Streptococcus anginosus constituted 82% of the 245 patient-unique isolates from hospitalized patients. All nonurinary isolates were involved in pyogenic infections mostly originating from the gastrointestinal tract, with bacteremia in 28 cases. The 71 urinary isolates represented either urinary tract infection or nonsignificant bacteriuria. No specific association could be detected between species and the infection site, except for a higher relative representation of Streptococcus constellatus in bacteremia. Milleri group streptococci are common in clinical practice and play a different pathogenic role to other viridans streptococci. Due to their invariable association with pyogenic processes, their presence in blood warrants immediate focus identification. In addition, they have a previously unappreciated clinical niche concerning urinary tract infection. The identification of viridans streptococci to the species level is of paramount clinical significance.


Urinary Tract Infection Bacteriuria Tertiary Care Teaching Hospital Viridans Streptococcus Bacteremic Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflict of interest

All authors: none.


  1. 1.
    Facklam R (2002) What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 15:613–630PubMedCrossRefGoogle Scholar
  2. 2.
    Piscitelli SC, Shwed J, Schreckenberger P, Danziger LH (1992) Streptococcus milleri group: renewed interest in an elusive pathogen. Eur J Clin Microbiol Infect Dis 11:491–498PubMedCrossRefGoogle Scholar
  3. 3.
    Gossling J (1988) Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis 10:257–285PubMedCrossRefGoogle Scholar
  4. 4.
    Whiley RA, Beighton D, Winstanley TG, Fraser HY, Hardie JM (1992) Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol 30:243–244PubMedGoogle Scholar
  5. 5.
    Jacobs JA, Pietersen HG, Stobberingh EE, Soeters PB (1994) Bacteremia involving the “Streptococcus milleri” group: analysis of 19 cases. Clin Infect Dis 19:704–713PubMedCrossRefGoogle Scholar
  6. 6.
    Casariego E, Rodriguez A, Corredoira JC, Alonso P, Coira A, Bal M, López MJ, Varela J (1996) Prospective study of Streptococcus milleri bacteremia. Eur J Clin Microbiol Infect Dis 15:194–200PubMedCrossRefGoogle Scholar
  7. 7.
    Salavert M, Gómez L, Rodriguez-Carballeira M, Xercavins M, Freixas N, Garau J (1996) Seven-year review of bacteremia caused by Streptococcus milleri and other viridans streptococci. Eur J Clin Microbiol Infect Dis 15:365–371PubMedCrossRefGoogle Scholar
  8. 8.
    Bert F, Bariou-Lancelin M, Lambert-Zechovsky N (1998) Clinical significance of bacteremia involving the “Streptococcus milleri” group: 51 cases and review. Clin Infect Dis 27:385–387PubMedCrossRefGoogle Scholar
  9. 9.
    Weightman NC, Barnham MR, Dove M (2004) Streptococcus milleri group bacteraemia in North Yorkshire, England (1989–2000). Indian J Med Res 119(Suppl):164–167PubMedGoogle Scholar
  10. 10.
    Stelzmueller I, Pfausler B, Fille M, Dossett LA, Bonatti H (2009) Streptococcus milleri group isolates from blood cultures: consider surgical sepsis. Surg Infect (Larchmt) 10:259–263CrossRefGoogle Scholar
  11. 11.
    Stelzmueller I, Biebl M, Berger N, Eller M, Mendez J, Fille M, Angerer K, Schmid T, Lorenz I, Margreiter R, Bonatti H (2007) Relevance of group milleri streptococci in thoracic surgery: a clinical update. Am Surg 73:492–497PubMedGoogle Scholar
  12. 12.
    Ripley RT, Cothren CC, Moore EE, Long J, Johnson JL, Haenel JB (2006) Streptococcus milleri infections of the pleural space: operative management predominates. Am J Surg 192:817–821PubMedCrossRefGoogle Scholar
  13. 13.
    Kowlessar PI, O’Connell NH, Mitchell RD, Elliott S, Elliott TS (2006) Management of patients with Streptococcus milleri brain abscesses. J Infect 52:443–450PubMedCrossRefGoogle Scholar
  14. 14.
    Hardwick RH, Taylor A, Thompson MH, Jones E, Roe AM (2000) Association between Streptococcus milleri and abscess formation after appendicitis. Ann R Coll Surg Engl 82:24–26PubMedGoogle Scholar
  15. 15.
    Stelzmueller I, Aigner F, Albright J, Margreiter R, Fille M, Swenson BR, Dossett L, Bonatti H (2010) Group Milleri Streptococci in perianal infections. Colorectal Dis 12:e121–e127PubMedGoogle Scholar
  16. 16.
    Rankhethoa NM, Prescott CA (2008) Significance of Streptococcus milleri in acute rhinosinusitis with complications. J Laryngol Otol 122:810–813PubMedCrossRefGoogle Scholar
  17. 17.
    Hirai T, Kimura S, Mori N (2005) Head and neck infections caused by Streptococcus milleri group: an analysis of 17 cases. Auris Nasus Larynx 32:55–58PubMedCrossRefGoogle Scholar
  18. 18.
    Belko J, Goldmann DA, Macone A, Zaidi AKM (2002) Clinically significant infections with organisms of the Streptococcus milleri group. Pediatr Infect Dis J 21:715–723PubMedCrossRefGoogle Scholar
  19. 19.
    Stelzmueller I, Fille M, Hager J, Dossett L, Sifri CD, Bonatti H (2009) Group Milleri Streptococci in paediatric infections. Eur J Pediatr Surg 19:21–24PubMedCrossRefGoogle Scholar
  20. 20.
    Jackson DS, Welch DF, Pickett DA, Mukwaya GM, Kuhls TL (1995) Suppurative infections in children caused by non-beta-hemolytic members of the Streptococcus milleri group. Pediatr Infect Dis J 14:80–82PubMedGoogle Scholar
  21. 21.
    Stelzmueller I, Berger N, Wiesmayr S, Eller M, Tabarelli W, Fille M, Margreiter R, Bonatti H (2007) Group milleri streptococci: significant pathogens in solid organ recipients. Transpl Int 20:51–56PubMedCrossRefGoogle Scholar
  22. 22.
    Parkins MD, Sibley CD, Surette MG, Rabin HR (2008) The Streptococcus milleri group—an unrecognized cause of disease in cystic fibrosis: a case series and literature review. Pediatr Pulmonol 43:490–497PubMedCrossRefGoogle Scholar
  23. 23.
    Molina JM, Leport C, Bure A, Wolff M, Michon C, Vilde JL (1991) Clinical and bacterial features of infections caused by Streptococcus milleri. Scand J Infect Dis 23:659–666PubMedCrossRefGoogle Scholar
  24. 24.
    Jacobs JA, Pietersen HG, Stobberingh EE, Soeters PB (1995) Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius. Clinical relevance, hemolytic and serologic characteristics. Am J Clin Pathol 104:547–553PubMedGoogle Scholar
  25. 25.
    Claridge JE 3rd, Attorri S, Musher DM, Hebert J, Dunbar S (2001) Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (“Streptococcus milleri group”) are of different clinical importance and are not equally associated with abscess. Clin Infect Dis 32:1511–1515PubMedCrossRefGoogle Scholar
  26. 26.
    Laupland KB, Ross T, Church DL, Gregson DB (2006) Population-based surveillance of invasive pyogenic streptococcal infection in a large Canadian region. Clin Microbiol Infect 12:224–230PubMedCrossRefGoogle Scholar
  27. 27.
    Funke G, Funke-Kissling P (2005) Performance of the new VITEK 2 GP card for identification of medically relevant gram-positive cocci in a routine clinical laboratory. J Clin Microbiol 43:84–88PubMedCrossRefGoogle Scholar
  28. 28.
    Haanperä M, Jalava J, Huovinen P, Meurman O, Rantakokko-Jalava K (2007) Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2. J Clin Microbiol 45:762–770PubMedCrossRefGoogle Scholar
  29. 29.
    Ruoff KL (1988) Streptococcus anginosus (“Streptococcus milleri”): the unrecognized pathogen. Clin Microbiol Rev 1:102–108PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  1. 1.Infectious Diseases UnitTel-Aviv Sourasky Medical CenterTel-AvivIsrael
  2. 2.Microbiology LaboratoryTel-Aviv Sourasky Medical CenterTel-AvivIsrael
  3. 3.Sackler School of MedicineTel-Aviv UniversityTel-AvivIsrael
  4. 4.Family Medical PracticeHanoiVietnam

Personalised recommendations